Short treatment duration for community-acquired pneumonia

被引:6
作者
Dinh, Aurelien [1 ,2 ,3 ,5 ]
Cremieux, Anne-Claude [4 ]
Guillemot, Didier [3 ]
机构
[1] Univ Hosp Raymond Poincare, AP HP, Ainfect Dis Unit, Garches, France
[2] Paris Saclay Univ, Antiinfect Evas & Pharmacoepidemiol Team, UVSQ, Inserm,CESP, Montigny Le Bretonneux, France
[3] Univ Paris, Inst Pasteur, Epidemiol & Modelling Antibiot Evas EMAE, Paris, France
[4] Univ Paris, St Louis Univ Hosp, Infect Dis Dept, AP HP, Paris, France
[5] Paris Saclay Univ, Univ Hosp Raymond Poincare, APHP, Infect Dis Unit, 104 Bd R Poincare, F-92380 Garches, France
关键词
antibiotic; bacterial resistance; pneumonia; treatment duration; INFECTIOUS-DISEASES-SOCIETY; ANTIBIOTIC-TREATMENT; DOUBLE-BLIND; EARLY SWITCH; HOSPITALIZED-PATIENTS; PRACTICE GUIDELINE; THORACIC-SOCIETY; BETA-LACTAM; ADULTS; RISK;
D O I
10.1097/QCO.0000000000000908
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of reviewLower respiratory tract infections are one of the most common indications for antibiotic use in community and hospital settings. Usual guidelines for adults with community-acquired pneumonia (CAP) recommend 5-7 days of antibiotic treatment. In daily practice, physicians often prescribe 9-10 days of antibiotic treatment. Among available strategies to decrease antibiotic use, possibly preventing the emergence of bacterial resistance, reducing treatment durations is the safest and the most acceptable to clinicians. We aim to review data evaluating the efficacy of short antibiotic duration in adult CAP and which criteria can help clinicians to reduce antibiotic treatment.Recent findingsSeveral studies and meta-analyses demonstrated that the treatment duration of 7 days or less was sufficient for CAP. Two trials found that 3-day treatments were effective, even in hospitalized CAP.To customize and shorten duration, clinical and biological criteria have been studied and reflect patient's response. Indeed, stability criteria were recently shown to be effective to discontinue antibiotic treatment. Procalcitonin was also studied but never compared with clinical criteria.Treatment duration for CAP is still under debate, but several studies support short durations. Clinical criteria could be possibly used to discontinue antibiotic treatment.
引用
收藏
页码:140 / 145
页数:6
相关论文
共 63 条
[31]   Epidemiology and etiology of community-acquired pneumonia [J].
Mandell, LA .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2004, 18 (04) :761-+
[32]   Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults [J].
Mandell, Lionel A. ;
Wunderink, Richard G. ;
Anzueto, Antonio ;
Bartlett, John G. ;
Campbell, G. Douglas ;
Dean, Nathan C. ;
Dowell, Scott F. ;
File, Thomas M., Jr. ;
Musher, Daniel M. ;
Niederman, Michael S. ;
Torres, Antonio ;
Whitney, Cynthia G. .
CLINICAL INFECTIOUS DISEASES, 2007, 44 :S27-S72
[33]   A controlled trial of a critical pathway for treatment of community-acquired pneumonia [J].
Marrie, TJ ;
Lau, CY ;
Wheeler, SL ;
Wong, CJ ;
Vandervoort, MK ;
Feagan, BG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (06) :749-755
[34]   Length of hospitalization in elderly patients with community-acquired pneumonia [J].
Masotti, L ;
Ceccarelli, E ;
Cappelli, R ;
Barabesi, L ;
Guerrini, M ;
Forconi, S .
AGING-CLINICAL AND EXPERIMENTAL RESEARCH, 2000, 12 (01) :35-41
[35]   TREATMENT OF PNEUMOCOCCAL PNEUMONIA WITH PENICILLIN [J].
MEADS, M ;
HARRIS, HW ;
FINLAND, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1945, 232 (26) :747-755
[36]   Duration of length of stay in pneumonia:: influence of clinical factors and hospital type [J].
Menéndez, R ;
Cremades, MJ ;
Martínez-Moragón, E ;
Soler, JJ ;
Reyes, S ;
Perpiña, M .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (04) :643-648
[37]   Diagnosis and Treatment of Adults with Community-acquired Pneumonia An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America [J].
Metlay, Joshua P. ;
Waterer, Grant W. ;
Long, Ann C. ;
Anzueto, Antonio ;
Brozek, Jan ;
Crothers, Kristina ;
Cooley, Laura A. ;
Dean, Nathan C. ;
Fine, Michael J. ;
Flanders, Scott A. ;
Griffin, Marie R. ;
Metersky, Mark L. ;
Musher, Daniel M. ;
Restrepo, Marcos, I ;
Whitney, Cynthia G. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 200 (07) :E45-E67
[38]  
NICE guideline, 2019, PNEUMONIA COMMUNITY
[39]   The cost of treating community-acquired pneumonia [J].
Niederman, MS ;
McCombs, JS ;
Unger, AN ;
Kumar, A ;
Popovian, R .
CLINICAL THERAPEUTICS, 1998, 20 (04) :820-837
[40]   Early switch from intravenous to oral antibiotics and early hospital discharge -: A prospective observational study of 200 consecutive patients with community-acquired pneumonia [J].
Ramirez, JA ;
Vargas, S ;
Ritter, GW ;
Brier, ME ;
Wright, A ;
Smith, S ;
Newman, D ;
Burke, J ;
Mushtaq, M ;
Huang, A .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (20) :2449-2454